m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00450)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
WIF1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Browse Drug
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
| Response Summary | ALKBH5 overexpression sensitizes Pancreatic cancer cells to gemcitabine treatment, and it represses PDAC tumorigenesis by reducing m6A levels of Wnt inhibitory factor 1 (WIF1) and hindering activation of Wnt signaling. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
| Responsed Drug | Gemcitabine | Approved | ||
| Pathway Response | Wnt signaling pathway | hsa04310 | ||
| In-vitro Model | AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 |
| BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
| Capan-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0237 | |
| Capan-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0026 | |
| CFPAC-1 | Cystic fibrosis | Homo sapiens | CVCL_1119 | |
| HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
| MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
| PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
Pancreatic cancer [ICD-11: 2C10]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
| Response Summary | ALKBH5 overexpression sensitizes Pancreatic cancer cells to gemcitabine treatment, and it represses PDAC tumorigenesis by reducing m6A levels of Wnt inhibitory factor 1 (WIF1) and hindering activation of Wnt signaling. | |||
| Responsed Disease | Pancreatic cancer [ICD-11: 2C10] | |||
| Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
| Target Regulation | Up regulation | |||
| Responsed Drug | Gemcitabine | Approved | ||
| Pathway Response | Wnt signaling pathway | hsa04310 | ||
| In-vitro Model | AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 |
| BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
| Capan-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0237 | |
| Capan-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0026 | |
| CFPAC-1 | Cystic fibrosis | Homo sapiens | CVCL_1119 | |
| HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
| MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
| PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
Gemcitabine
[Approved]
| In total 1 item(s) under this drug | ||||
| Experiment 1 Reporting the m6A-centered Drug Response | [2] | |||
| Response Summary | ALKBH5 overexpression sensitizes Pancreatic cancer cells to gemcitabine treatment, and it represses PDAC tumorigenesis by reducing m6A levels of Wnt inhibitory factor 1 (WIF1) and hindering activation of Wnt signaling. | |||
| Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
| Target Regulation | Up regulation | |||
| Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
| Pathway Response | Wnt signaling pathway | hsa04310 | ||
| In-vitro Model | AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 |
| BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
| Capan-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0237 | |
| Capan-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0026 | |
| CFPAC-1 | Cystic fibrosis | Homo sapiens | CVCL_1119 | |
| HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
| MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
| PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Non-coding RNA
m6A Regulator: Methyltransferase-like 3 (METTL3)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05304 | ||
| Epigenetic Regulator | hsa-miR-21-5p | |
| Regulated Target | Methyltransferase-like protein 3 (METTL3) | |
| Crosstalk relationship | ncRNA → m6A | |
| Disease | Endometriosis | |
RNA Modification Sequencing Data Associated with the Target (ID: M6ATAR00450)
| In total 1 m6A sequence/site(s) in this target gene | |||
| mod ID: A2ISITE005631 | Click to Show/Hide the Full List | ||
| mod site | chr12:65056474-65056475:- | [3] | |
| Sequence | CCAGCACTTTTGAGAGGCCAAGGCGGGCGGATCACTTGAGG | ||
| Transcript ID List | ENST00000543094.1; ENST00000286574.9; rmsk_3814473 | ||
| External Link | RMBase: RNA-editing_site_29757 | ||
5-methylcytidine (m5C)
| In total 1 m6A sequence/site(s) in this target gene | |||
| mod ID: M5CSITE000071 | Click to Show/Hide the Full List | ||
| mod site | chr12:65068799-65068800:- | [4] | |
| Sequence | GCAACACCATTCTCCAAACACCTCAAAATGCTATCTTCTTT | ||
| Seq Type List | Bisulfite-seq | ||
| Transcript ID List | ENST00000286574.9; ENST00000546001.1 | ||
| External Link | RMBase: m5C_site_10594 | ||
N6-methyladenosine (m6A)
| In total 1 m6A sequence/site(s) in this target gene | |||
| mod ID: M6ASITE013754 | Click to Show/Hide the Full List | ||
| mod site | chr12:65068872-65068873:- | [5] | |
| Sequence | GGTTTCCCATGTCTTGGAAAACAGGATGGGGTGGCAGCATT | ||
| Motif Score | 2.20572619 | ||
| Cell/Tissue List | brain | ||
| Seq Type List | m6A-REF-seq | ||
| Transcript ID List | ENST00000546001.1; ENST00000286574.9 | ||
| External Link | RMBase: m6A_site_197228 | ||
References